Matthew Ellis

Citado por

	Total	Desde 2017
Citas	73573	40331
Índice h	109	81
Índice i10	298	242

8000

4000

2000

6000

200220032004200520062007200820092010201120122013201420152016201720182019202020212022257 410 472 618 897 1098 1267 1462 1740 2236 2686 3839 4405 4977 5580 6112 6033 6551 6897 7974 6645

Acceso público

Ver todo

193 artículos

4 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Torsten NielsenProfessor of Pathology, University of British ColumbiaDirección de correo verificada de mail.ubc.ca
Elaine MardisOhio State UniversityDirección de correo verificada de nationwidechildrens.org
Daniel F. Hayesprofessor internal medicineDirección de correo verificada de umich.edu
Joel ParkerUniversity of North Carolina at Chapel HillDirección de correo verificada de email.unc.edu
Maggie CheangTHE INSTITUTE OF CANCER RESEARCHDirección de correo verificada de icr.ac.uk
Charles M. PerouUniversity of North Carolina at Chapel HillDirección de correo verificada de med.unc.edu
George Thomas BuddDirección de correo verificada de ccf.org
MarcomProfessor of Medicine, Duke UniversityDirección de correo verificada de duke.edu
Stephen KL ChiaMedical Oncology, British Columbia Cancer AgencyDirección de correo verificada de bccancer.bc.ca
Kathleen I. PritchardProfessor, Division of Medical Oncology, University of TorontoDirección de correo verificada de sunnybrook.ca
Meenakshi AnuragAssistant Professor, Baylor College of MedicineDirección de correo verificada de bcm.edu
Feng GaoWashington University School of MedicineDirección de correo verificada de wustl.edu
Jonathan LeiBaylor College of MedicineDirección de correo verificada de bcm.edu
Obi L. GriffithAssociate Professor, Washington University School of MedicineDirección de correo verificada de wustl.edu
William (Bill) BarryPrincipal Statistical Reseach Scientist, Rho, IncDirección de correo verificada de rhoworld.com
Malachi GriffithAssociate Professor, Medicine, Washington University School of MedicineDirección de correo verificada de wustl.edu
Donald Berryprofessor of biostatistics, m.d. anderson cancer centerDirección de correo verificada de mdanderson.org
Matthew P. GoetzErivan K. Haub Family Professor of Cancer Research Honoring Richard F. Emslander, M.D., Mayo ClinicDirección de correo verificada de mayo.edu
Antonio C. Wolff, MD, FACP, FASCOProfessor of Oncology, Johns Hopkins UniversityDirección de correo verificada de jhmi.edu
James ReubenProfessor, University of Texas MD Anderson Cancer CenterDirección de correo verificada de mdanderson.org

Seguir

Matthew Ellis

Professor of Medicine and Cellular and Molecular Biology

Dirección de correo verificada de bcm.edu - Página principal

breast cancer cancer genomics cancer proteomics


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Comprehensive molecular portraits of human breast tumours Cancer Genome Atlas Network Nature 490 (7418), 61-70, 2012	9742*	2012
Circulating tumor cells, disease progression, and survival in metastatic breast cancer M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, J Matera, MC Miller, ... New England Journal of Medicine 351 (8), 781-791, 2004	4896	2004
Supervised risk predictor of breast cancer based on intrinsic subtypes JS Parker, M Mullins, MCU Cheang, S Leung, D Voduc, T Vickery, ... Journal of clinical oncology 27 (8), 1160-1167, 2009	4483	2009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer MCU Cheang, SK Chia, D Voduc, D Gao, S Leung, J Snider, M Watson, ... JNCI: Journal of the National Cancer Institute 101 (10), 736-750, 2009	2825	2009
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National Cancer Institute 103 (22), 1656-1664, 2011	1803	2011
The molecular portraits of breast tumors are conserved across microarray platforms Z Hu, C Fan, DS Oh, JS Marron, X He, BF Qaqish, C Livasy, LA Carey, ... BMC genomics 7 (1), 1-12, 2006	1767	2006
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 379 (2), 111-121, 2018	1543	2018
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1–and/or ErbB-2–positive, estrogen receptor–positive primary breast cancer: evidence from a … MJ Ellis, A Coop, B Singh, L Mauriac, A Llombert-Cussac, F Jänicke, ... Journal of Clinical Oncology 19 (18), 3808-3816, 2001	1401	2001
Prospective validation of a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 373 (21), 2005-2014, 2015	1307	2015
Genome remodelling in a basal-like breast cancer metastasis and xenograft LI Ding, MJ Ellis, S Li, DE Larson, K Chen, JW Wallis, CC Harris, ... Nature 464 (7291), 999-1005, 2010	1300	2010
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer M Cristofanilli, DF Hayes, GT Budd, MJ Ellis, A Stopeck, JM Reuben, ... Journal of Clinical Oncology 23 (7), 1420-1430, 2005	1297	2005
Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016	1291	2016
Proteogenomic characterization of human colon and rectal cancer B Zhang, J Wang, X Wang, J Zhu, Q Liu, Z Shi, MC Chambers, ... Nature 513 (7518), 382-387, 2014	1216	2014
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival DF Hayes, M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, MC Miller, ... Clinical Cancer Research 12 (14), 4218-4224, 2006	1127	2006
Whole-genome analysis informs breast cancer response to aromatase inhibition MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ... Nature 486 (7403), 353-360, 2012	1110	2012
Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer GT Budd, M Cristofanilli, MJ Ellis, A Stopeck, E Borden, MC Miller, ... Clinical Cancer Research 12 (21), 6403-6409, 2006	908	2006
Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study W Eiermann, S Paepke, J Appfelstaedt, A Llombart-Cussac, J Eremin, ... Annals of Oncology 12 (11), 1527-1532, 2001	890	2001
CDK4/6 inhibition triggers anti-tumour immunity S Goel, MJ DeCristo, AC Watt, H BrinJones, J Sceneay, BB Li, N Khan, ... Nature 548 (7668), 471-475, 2017	883	2017
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast cancer TO Nielsen, JS Parker, S Leung, D Voduc, M Ebbert, T Vickery, SR Davies, ... Clinical Cancer Research 16 (21), 5222-5232, 2010	809	2010
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on … CK Osborne, J Pippen, SE Jones, LM Parker, M Ellis, S Come, SZ Gertler, ... Journal of Clinical Oncology 20 (16), 3386-3395, 2002	791	2002

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores